2 results
Approved WMOCompleted
The primary objective is to demonstrate the safety and feasibility of the STENTYS-BDS.
Approved WMORecruiting
The primary objective of this study is to compare, in a randomized phase III trial, the effect of 10-day decitabine at a dose of 20 mg/m2 versus conventional induction chemotherapy (*3+7*) on OS in older AML patients.